Vivos Inc (RDGL): IDE submit will be very very soon:...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Vivos Inc (RDGL)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	201
Posts	23338
Boards Moderated	1
Alias Born	01/06/2005

Re: konshe post# 168991

Friday, 12/22/2023 9:23:38 AM

Friday, December 22, 2023 9:23:38 AM

IDE submit will be very very soon:

With the Breakthrough Device classification, Vivos Inc. is set to expedite its Investigational Device Exemption (IDE) submission to the FDA, paving the way for human clinical trials. This collaboration with the Mayo Clinic for its initial indication marks a significant step forward in the fight against challenging cancer types, offering hope and potentially more effective treatment options to patients globally.

Bullish

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RDGL News

Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM

More RDGL News

InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow